FDA inspection
Celgene International Sarl: FDA inspection ending Sep 15, 2017
FDA inspection 1026576 · Voluntary Action Indicated (VAI) · Boudry
Key facts
| Inspection ID | 1026576 |
|---|---|
| Firm | Celgene International Sarl |
| FEI number | 3006323509 |
| Address | Route De Perreux 1 |
| City | Boudry |
| Country | Switzerland |
| Fiscal year | 2017 |
| Inspection end date | Sep 15, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data